Tratamiento ortopodológico de artrosis en mediopié: un caso clínico.
Loading...
Official URL
Full text at PDC
Publication date
2025
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Abstract
La osteoartrosis (OA) de mediopié es una afección degenerativa común e incapacitante que afecta negativamente la función física y reduce significativamente la calidad de vida. No existen criterios de diagnóstico clínico aceptados para la OA del pie, por lo que las radiografías simples siguen siendo las más utilizadas en la práctica clínica. El manejo de la artrosis de mediopié se extrapola en gran medida de los estudios de artrosis en otras localizaciones de los miembros inferiores. A pesar de la alta prevalencia de la OA de mediopié, existen pocos estudios sobre las opciones de tratamiento conservadoras, por lo que se necesitan ensayos clínicos sólidos para ampliar el conocimiento en este ámbito.
Midfoot osteoarthritis (OA) is a common and disabling degenerative condition that negatively affects physical function and significantly reduces quality of life. There are no accepted clinical diagnostic criteria for foot OA, so plain radiographs remain the most widely used in clinical practice. The management of midfoot osteoarthritis is largely extrapolated from studies of osteoarthritis in other locations of the lower limbs. Despite the high prevalence of midfoot OA, there are few studies on conservative treatment options, and robust clinical trials are needed to expand knowledge in this area.
Midfoot osteoarthritis (OA) is a common and disabling degenerative condition that negatively affects physical function and significantly reduces quality of life. There are no accepted clinical diagnostic criteria for foot OA, so plain radiographs remain the most widely used in clinical practice. The management of midfoot osteoarthritis is largely extrapolated from studies of osteoarthritis in other locations of the lower limbs. Despite the high prevalence of midfoot OA, there are few studies on conservative treatment options, and robust clinical trials are needed to expand knowledge in this area.